Hetero Drugs - Revision history

Sshekhar898: Page updated with relevant improvements

2025-12-30T12:56:19Z

Page updated with relevant improvements

← Older revision		Revision as of 18:26, 30 December 2025
Line 1:		Line 1:
	{{Short description\|An Indian pharmaceutical company}}		{{Short description\|Indian pharmaceutical company}}
	{{Use dmy dates\|date=~~July 2018~~}}		{{Use dmy dates\|date=April 2024}}
	{{Use Indian English\|date=July 2018}}		{{Use Indian English\|date=July 2018}}
	{{Infobox company		{{Infobox company
	\| name = Hetero Drugs Limited		\| name = Hetero Drugs Limited
	\| logo = ~~HETERO DRUGS logo~~.~~png~~		\| logo = Hetero_Drugs_Logo.svg
	\| type = Private		\| type = Private
	\| industry = [[Pharmaceuticals]]		\| industry = [[Pharmaceuticals]]
	\| foundation = 1993		\| foundation = 1993
	\| founder = Dr ~~BPS~~ Reddy		\| founder = Dr. [[B. Parthasaradhi Reddy]]
	\| location = [[Hyderabad]], [[India]]		\| location = [[Hyderabad]], [[India]]
	\| key_people = Dr Vamsi Reddy		\| key_people = Dr. B. Vamsi Krishna Reddy
	\| num_employees = Over 22,000		\| num_employees = Over 22,000
	\| homepage = ~~[http://www.heteroworld.com www.heteroworld.com]~~		\| homepage = {{official URL}}
	}}		}}
	'''Hetero Drugs''' is an Indian [[pharmaceutical]] company and the ~~world’s~~ largest producer of anti-retroviral drugs. ~~Hetero’s~~ business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.		'''Hetero Drugs''' is an Indian [[pharmaceutical]] company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.

	==Operations==		==Operations==
	Hetero group employs over 21,000 people. Hetero is a ~~player~~ in the [[active pharmaceutical ingredients]] market and finished dosages.<ref name="hep-c-news1">{{cite web \|url=http://hep-c-news.com/hepatitis-c-treatment-in-india-for-less-than-1000/ \|title=~~Archived copy~~ \|access-date=2016-07-11 \|url-status=dead \|archive-url=https://web.archive.org/web/20160916124038/http://hep-c-news.com/blog/2016/07/11/hepatitis-c-treatment-in-india-for-less-than-1000/ \|archive-date=2016-09-16 }}</ref> It has marketing presence in over ~~127~~ countries.		Hetero group employs over 22,000 people. Hetero is a participant in the [[active pharmaceutical ingredients]] market and finished dosages.<ref name="hep-c-news1">{{cite web \|url=http://hep-c-news.com/hepatitis-c-treatment-in-india-for-less-than-1000/ \|title=Hepatitis C treatment in India for less than $1000 \| Hep C News - Hepatitis C Treatment, Cure Rate and Cost \|access-date=2016-07-11 \|url-status=dead \|archive-url=https://web.archive.org/web/20160916124038/http://hep-c-news.com/blog/2016/07/11/hepatitis-c-treatment-in-india-for-less-than-1000/ \|archive-date=2016-09-16 }}</ref> It has marketing presence in over 140 countries.

	Hetero ~~has supplied antiretroviral drugs to patients across more than 100 countries globally.~~<ref>{{cite ~~web\|url=http://www.heterodrugs.com/abt-fightagainsthiv.shtml~~ \|~~title~~=~~:: Welcome to Hetero ::~~ \|~~publisher~~=~~Heterodrugs~~.~~com~~ \|~~access-date~~=~~2014-01-11~~ \|~~url-status=dead \|archive-~~url=https://~~web~~.~~archive.org~~/~~web~~/~~20140117162600~~/~~http://www.heterodrugs.com/abt~~-~~fightagainsthiv~~.~~shtml~~ \|~~archive~~-date=~~2014-01-17 }}</ref>~~		Hetero Group's subsidiaries include Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharmaceuticals in the [[United States]],<ref>{{cite news \|last1=Walsh \|first1=James D. \|title=The Empty Adderall Factory \|url=https://nymag.com/intelligencer/article/adderall-shortage-adhd-medication-ascent-pharmaceuticals.html \|access-date=20 February 2024 \|work=Intelligencer \|date=19 February 2024}}</ref> Hetero Europe in [[Europe]], Amarox Pharma Global in [[Indonesia]], and Richmond Labs in [[Argentina]]. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017.<ref>{{cite web\|url=http://www.heterowindpower.com/\|title=Hetero Windpower\|publisher=Hetero\|access-date=22 June 2018}}</ref>

	~~Today, [[Oseltamivir]], sold under its brand name [[Fluvir]], is also indicated for A[H1N1] virus, also known as [[swine flu]].{{citation needed~~\|~~date~~=~~June 2018}}~~

	~~Hetero also produces hepatitis C antivirals such as Sofovir ([[sofosbuvir]]) and Ledifos (a fixed-dose combination of [[sofosbuvir]] and [[ledipasvir]]).{{citation needed~~\|date=~~June 2018~~}}

	~~==Company structure==~~
	Hetero ~~Group's subsidiaries include Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharma Inc.~~ in [[~~United States~~]], ~~Hetero Europe~~ in [[~~Europe~~]], and Richmond Labs in [[Argentina]]. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017.<ref>{{cite web\|url=http://www.heterowindpower.com/\|title=Hetero Windpower\|publisher=Hetero\|access-date=22 June 2018}}</ref>

	==2009 Swine flu outbreak==		==2009 Swine flu outbreak==
	In 2009, as the [[swine flu]] outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name [[Fluvir]].<ref>[http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm Swine flu: Centre taps Hetero for generic Tamiflu supply]{{webarchive \|url=https://web.archive.org/web/20090430031832/http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm \|date=30 April 2009 }}</ref>		In 2009, as the [[swine flu]] outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name [[Fluvir]].<ref>[http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm Swine flu: Centre taps Hetero for generic Tamiflu supply]{{webarchive \|url=https://web.archive.org/web/20090430031832/http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm \|date=30 April 2009 }}</ref>

	Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009,<ref>{{cite web\|author=Khomba Singh~~, ET Bureau 5 May 2009, 12.03am IST~~ \|url=http://economictimes.indiatimes.com/News-by-Industry/Hetero-bags-govts-anti-flu-drug-deal/articleshow/4484144.cms \|title=Hetero bags mega chunk of govt's anti-flu drug deal - Economic Times ~~\|publisher=Economictimes.indiatimes.com~~ \|date=2009-05-05 \|access-date=2014-01-11}}</ref> and shipped about 80 million doses to over 60 countries.<ref>{{cite web\|url=http://www.moneycontrol.com/india/news/cnbc-tv18-comments/hyderabad-pharma-cos-cashon-swine-flu-fever/411305 \|title=Hyderabad pharma cos cash in on Swine-Flu fever \|publisher=Moneycontrol.com \|access-date=2014-01-11}}</ref> Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.<ref>{{cite web\|author=Khomba Singh~~, ET Bureau 22 August 2009, 03.02am IST~~ \|url=http://economictimes.indiatimes.com/News/News-By-Industry/Healthcare-Biotech/Pharmaceuticals/Hetero-bags-deal-for-10-m-Tamiflu/articleshow/4921285.cms \|title=Hetero bags deal for 10 m Tamiflu - Economic Times ~~\|publisher=Economictimes.indiatimes.com~~ \|date=2009-08-22 \|access-date=2014-01-11}}</ref>		Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009,<ref>{{cite web\|author=Khomba Singh\|url=http://economictimes.indiatimes.com/News-by-Industry/Hetero-bags-govts-anti-flu-drug-deal/articleshow/4484144.cms \|title=Hetero bags mega chunk of govt's anti-flu drug deal \|work=The Economic Times \|date=2009-05-05 \|access-date=2014-01-11}}</ref> and shipped about 80 million doses to over 60 countries.<ref>{{cite web\|url=http://www.moneycontrol.com/india/news/cnbc-tv18-comments/hyderabad-pharma-cos-cashon-swine-flu-fever/411305 \|title=Hyderabad pharma cos cash in on Swine-Flu fever \|publisher=Moneycontrol.com \|access-date=2014-01-11}}</ref> Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.<ref>{{cite web\|author=Khomba Singh\|url=http://economictimes.indiatimes.com/News/News-By-Industry/Healthcare-Biotech/Pharmaceuticals/Hetero-bags-deal-for-10-m-Tamiflu/articleshow/4921285.cms \|title=Hetero bags deal for 10 m Tamiflu\|work=The Economic Times \|date=2009-08-22 \|access-date=2014-01-11}}</ref>

	==COVID-19 experimental drugs==		==COVID-19 experimental drugs==
	The company has launched the generic version of experimental [[COVID-19]] drug ''[[Remdesivir]]'' under brand name '''Covifor''' after acquiring license from [[Gilead Sciences]] and obtaining approval from [[Central Drugs Standard Control Organisation\|CDSCO]], the Indian drug control authority.<ref>{{cite news \|title=Covid-19: Hyderabad-based Hetero Labs Ltd prices generic version of remdesivir at Rs 5,400 per vial \|url=https://indianexpress.com/article/cities/hyderabad/coronavirus-drug-remdesivir-generic-version-price-6475304/ \|work=The Indian Express \|date=25 June 2020 ~~\|language=en~~}}</ref> On July 29, ~~2020~~ the company launched its version of the anti viral drug [[Favipiravir]] under the brand name Favivir, after getting approval from [[Drugs Controller General of India]] (DCGI), used in the treatment of mild to moderate [[COVID-19]] patients.<ref>{{Cite news\|last=Kumar\|first=N. Ravi\|date=2020-07-29\|title=India's Hetero Labs wins approval to sell COVID-19 drug favipiravir~~\|language=en-IN~~\|work=The Hindu\|url=https://www.thehindu.com/news/national/indias-hetero-labs-wins-approval-to-sell-covid-19-drug-favipiravir/article32218999.ece\|access-date=2020-09-09\|issn=0971-751X}}</ref> On November ~~27,~~ 2020, Hetero Labs signed an agreement with the [[Russian Direct Investment Fund\|Russian Direct Investment Fund (RDIF)]] to manufacture 100 million doses of the [[Gam-COVID-Vac\|Sputnik V vaccine]].<ref>{{Cite news\|last=Das\|first=Sohini\|date=2020-11-27\|title=Hetero Labs to manufacture 100 mn doses of Sputnik V vaccine for India\|work=Business Standard India\|url=https://www.business-standard.com/article/companies/hetero-labs-to-manufacture-100-mn-doses-of-sputnik-v-vaccine-for-india-120112700495_1.html\|access-date=2020-11-28}}</ref>		The company has launched the generic version of experimental [[COVID-19]] drug ''[[Remdesivir]]'' under brand name '''Covifor''' after acquiring license from [[Gilead Sciences]] and obtaining approval from [[Central Drugs Standard Control Organisation\|CDSCO]], the Indian drug control authority.<ref>{{cite news \|title=Covid-19: Hyderabad-based Hetero Labs Ltd prices generic version of remdesivir at Rs 5,400 per vial \|url=https://indianexpress.com/article/cities/hyderabad/coronavirus-drug-remdesivir-generic-version-price-6475304/ \|work=The Indian Express \|date=25 June 2020}}</ref> On 29 July 2020, the company launched its version of the anti viral drug [[Favipiravir]] under the brand name Favivir, after getting approval from [[Drugs Controller General of India]] (DCGI), used in the treatment of mild to moderate [[COVID-19]] patients.<ref>{{Cite news\|last=Kumar\|first=N. Ravi\|date=2020-07-29\|title=India's Hetero Labs wins approval to sell COVID-19 drug favipiravir\|work=The Hindu\|url=https://www.thehindu.com/news/national/indias-hetero-labs-wins-approval-to-sell-covid-19-drug-favipiravir/article32218999.ece\|access-date=2020-09-09\|issn=0971-751X}}</ref> On 27 November 2020, Hetero Labs signed an agreement with the [[Russian Direct Investment Fund\|Russian Direct Investment Fund (RDIF)]] to manufacture 100 million doses of the [[Gam-COVID-Vac\|Sputnik V vaccine]].<ref>{{Cite news\|last=Das\|first=Sohini\|date=2020-11-27\|title=Hetero Labs to manufacture 100 mn doses of Sputnik V vaccine for India\|work=Business Standard India\|url=https://www.business-standard.com/article/companies/hetero-labs-to-manufacture-100-mn-doses-of-sputnik-v-vaccine-for-india-120112700495_1.html\|access-date=2020-11-28}}</ref>

	==References==		==References==

2601:197:602:ECE0:146B:D79D:19E7:E364: Fixed typo

2021-10-11T22:57:48Z

Fixed typo

← Older revision	Revision as of 04:27, 12 October 2021
(No difference)

2401:4900:4CA6:7C55:1CA1:5106:CCCF:D6DE: /* 2009 Swine flu outbreak */

2021-06-22T09:57:34Z

2009 Swine flu outbreak

New page

{{Short description|An Indian pharmaceutical company}}
{{Use dmy dates|date=July 2018}}
{{Use Indian English|date=July 2018}}
{{Infobox company
| name = Hetero Drugs Limited
| logo = HETERO DRUGS logo.png
| type = Private
| industry = [[Pharmaceuticals]]
| foundation = 1993
| founder = Dr BPS Reddy
| location = [[Hyderabad]], [[India]]
| key_people = Dr Vamsi Reddy
| num_employees = Over 22,000
| homepage = [http://www.heteroworld.com www.heteroworld.com]
}}
'''Hetero Drugs''' is an Indian [[pharmaceutical]] company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.

==Operations==
Hetero group employs over 21,000 people. Hetero is a player in the [[active pharmaceutical ingredients]] market and finished dosages.<ref name="hep-c-news1">{{cite web |url=http://hep-c-news.com/hepatitis-c-treatment-in-india-for-less-than-1000/ |title=Archived copy |access-date=2016-07-11 |url-status=dead |archive-url=https://web.archive.org/web/20160916124038/http://hep-c-news.com/blog/2016/07/11/hepatitis-c-treatment-in-india-for-less-than-1000/ |archive-date=2016-09-16 }}</ref> It has marketing presence in over 127 countries.

Hetero has supplied antiretroviral drugs to patients across more than 100 countries globally.<ref>{{cite web|url=http://www.heterodrugs.com/abt-fightagainsthiv.shtml |title=:: Welcome to Hetero :: |publisher=Heterodrugs.com |access-date=2014-01-11 |url-status=dead |archive-url=https://web.archive.org/web/20140117162600/http://www.heterodrugs.com/abt-fightagainsthiv.shtml |archive-date=2014-01-17 }}</ref>

Today, [[Oseltamivir]], sold under its brand name [[Fluvir]], is also indicated for A[H1N1] virus, also known as [[swine flu]].{{citation needed|date=June 2018}}

Hetero also produces hepatitis C antivirals such as Sofovir ([[sofosbuvir]]) and Ledifos (a fixed-dose combination of [[sofosbuvir]] and [[ledipasvir]]).{{citation needed|date=June 2018}}

==Company structure==
Hetero Group's subsidiaries include Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharma Inc. in [[United States]], Hetero Europe in [[Europe]], and Richmond Labs in [[Argentina]]. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017.<ref>{{cite web|url=http://www.heterowindpower.com/|title=Hetero Windpower|publisher=Hetero|access-date=22 June 2018}}</ref>

==2009 Swine flu outbreak==
In 2009, as the [[swine flu]] outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name [[Fluvir]].<ref>[http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm Swine flu: Centre taps Hetero for generic Tamiflu supply]{{webarchive |url=https://web.archive.org/web/20090430031832/http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm |date=30 April 2009 }}</ref>

Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009,<ref>{{cite web|author=Khomba Singh, ET Bureau 5 May 2009, 12.03am IST |url=http://economictimes.indiatimes.com/News-by-Industry/Hetero-bags-govts-anti-flu-drug-deal/articleshow/4484144.cms |title=Hetero bags mega chunk of govt's anti-flu drug deal - Economic Times |publisher=Economictimes.indiatimes.com |date=2009-05-05 |access-date=2014-01-11}}</ref> and shipped about 80 million doses to over 60 countries.<ref>{{cite web|url=http://www.moneycontrol.com/india/news/cnbc-tv18-comments/hyderabad-pharma-cos-cashon-swine-flu-fever/411305 |title=Hyderabad pharma cos cash in on Swine-Flu fever |publisher=Moneycontrol.com |access-date=2014-01-11}}</ref> Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.<ref>{{cite web|author=Khomba Singh, ET Bureau 22 August 2009, 03.02am IST |url=http://economictimes.indiatimes.com/News/News-By-Industry/Healthcare-Biotech/Pharmaceuticals/Hetero-bags-deal-for-10-m-Tamiflu/articleshow/4921285.cms |title=Hetero bags deal for 10 m Tamiflu - Economic Times |publisher=Economictimes.indiatimes.com |date=2009-08-22 |access-date=2014-01-11}}</ref>

==COVID-19 experimental drugs==
The company has launched the generic version of experimental [[COVID-19]] drug ''[[Remdesivir]]'' under brand name '''Covifor''' after acquiring license from [[Gilead Sciences]] and obtaining approval from [[Central Drugs Standard Control Organisation|CDSCO]], the Indian drug control authority.<ref>{{cite news |title=Covid-19: Hyderabad-based Hetero Labs Ltd prices generic version of remdesivir at Rs 5,400 per vial |url=https://indianexpress.com/article/cities/hyderabad/coronavirus-drug-remdesivir-generic-version-price-6475304/ |work=The Indian Express |date=25 June 2020 |language=en}}</ref> On July 29, 2020 the company launched its version of the anti viral drug [[Favipiravir]] under the brand name Favivir, after getting approval from [[Drugs Controller General of India]] (DCGI), used in the treatment of mild to moderate [[COVID-19]] patients.<ref>{{Cite news|last=Kumar|first=N. Ravi|date=2020-07-29|title=India's Hetero Labs wins approval to sell COVID-19 drug favipiravir|language=en-IN|work=The Hindu|url=https://www.thehindu.com/news/national/indias-hetero-labs-wins-approval-to-sell-covid-19-drug-favipiravir/article32218999.ece|access-date=2020-09-09|issn=0971-751X}}</ref> On November 27, 2020, Hetero Labs signed an agreement with the [[Russian Direct Investment Fund|Russian Direct Investment Fund (RDIF)]] to manufacture 100 million doses of the [[Gam-COVID-Vac|Sputnik V vaccine]].<ref>{{Cite news|last=Das|first=Sohini|date=2020-11-27|title=Hetero Labs to manufacture 100 mn doses of Sputnik V vaccine for India|work=Business Standard India|url=https://www.business-standard.com/article/companies/hetero-labs-to-manufacture-100-mn-doses-of-sputnik-v-vaccine-for-india-120112700495_1.html|access-date=2020-11-28}}</ref>

==References==
{{Reflist}}

{{Authority control}}

[[Category:Pharmaceutical companies of India]]
[[Category:Manufacturing companies based in Hyderabad, India]]
[[Category:Pharmaceutical companies established in 1993]]
[[Category:1993 establishments in Andhra Pradesh]]